Combined therapy with intravitreal aflibercept and subtenon corticosteroids in eyes with severe diabetic papillopathy: two case reports
Open Access
- 22 October 2021
- journal article
- case report
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 15 (1) , 1-6
Abstract
Diabetic papillopathy is a rare diagnosis of exclusion characterized by unilateral or bilateral optic disc edema with variable degrees of visual loss. Although the visual prognosis has been generally reported as favorable, the presence of severe disc edema associated with macular edema prompts the need for treatment. We present a specific and unreported therapeutic approach consisting of intravitreal aflibercept and subtenon triamcinolone acetonide injections in two patients with evidence of diabetic papillopathy and macular edema. In the first case, a 60-year-old Caucasian woman affected by type II diabetes mellitus presented with fundoscopic evidence of sequential bilateral optic disc edema associated with acute severe visual loss in both eyes. The second patient, a diabetic 57-year-old Caucasian male, presented with sudden painless visual loss in his left eye. Multimodal imaging and systemic findings correlated towards an infrequent diagnosis of diabetic papillopathy. In a period of 5–7 weeks after treatment, both patients experienced almost full visual and anatomical recovery. A steady situation was observed at 12 months of follow-up. Both our cases displayed a severe grade of optic disc edema, which was optimally reversed with intravitreal aflibercept and subtenon triamcinolone acetonide leading to a relatively rapid and safe improvement in visual acuity.Keywords
This publication has 31 references indexed in Scilit:
- Diabetic papillopathy with macular edema treated with intravitreal ranibizumabClinical Ophthalmology, 2013
- Intravitreal Bevacizumab for Diabetic PapillopathyJournal of Ocular Pharmacology and Therapeutics, 2010
- Diabetic Papillopathy and Its Relation to Optic Nerve IschemiaOptometry and Vision Science, 2009
- A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular EdemaOphthalmology, 2008
- Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edemaBMC Ophthalmology, 2008
- Intravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular EdemaKorean Journal of Ophthalmology, 2006
- Posterior subtenon triamcinolone acetonide for refractory diabetic macular edemaAmerican Journal of Ophthalmology, 2005
- Intravitreal triamcinolone acetonide for the management of diabetic papillopathyAmerican Journal of Ophthalmology, 2004
- Periocular corticosteroids in diabetic papillopathyEye, 2004
- Vascular Optic Neuropathy in Diabetes MellitusJapanese Journal of Ophthalmology, 1997